Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

VIE/MRK stock hub

VIE/MRK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VIE/MRKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

233.7B

Vienna Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

VIE/MRK

In the news

Latest news · VIE/MRK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.9

P25 10.6P50 13.8P75 15.8

Trailing P/E30.2

P25 13.1P50 25.1P75 27.6

ROE18.9

P25 -35.3P50 9.5P75 14.2

ROIC21.2

P25 -15.6P50 0.6P75 11.7

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VIE/MRK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AT
Employees	74,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 270.6B
Exchange	Vienna Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US58933Y1055
Last refreshed	2026-05-10
Market cap	EUR 233.7B
Price	EUR 95.28
Price currency	EUR
Rev Per Employee	770,818.74x
Sector	Healthcare
Sic	2834
Symbol	vie/MRK
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.32%
EV Earnings	34.93x
EV/EBIT	12.98x
EV/EBITDA	10.64x
EV/FCF	22.11x
EV/Sales	4.84x
FCF yield	5.24%
Forward P/E	17.9x
P/B ratio	5.87x
P/E ratio	30.16x
P/S ratio	4.1x
PE Ratio10 Y	54.31x
PE Ratio3 Y	99.8x
PE Ratio5 Y	67.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	37.3%
EBITDA Margin	44.88%
FCF margin	21.46%
Gross margin	76.73%
Gross Profit	EUR 43.8B
Gross Profit Growth	2.43%
Gross Profit Growth Q	2.18%
Gross Profit Growth3 Y	6.22%
Gross Profit Growth5 Y	10.9%
Net Income	EUR 7.7B
Net Income Growth	-48.75%
Net Income Growth3 Y	-11.82%
Net Income Growth5 Y	4.92%
Pretax Margin	17.68%
Profit Margin	13.59%
Profit Per Employee	EUR 104,721
ROA	12.58
Roa5y	11.18
ROCE	24.11
ROE	18.94
Roe5y	30.37
ROIC	21.18
Roic5y	22.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	40.58%
Cagr3y	-0.65%
Cagr5y	11.63%
Div CAGR3	1.71%
Div CAGR5	6.05%
EPS Growth	-48.02
EPS Growth3 Y	-11.28
EPS Growth5 Y	5.25
FCF Growth	-17.16%
FCF Growth Q	149.74%
FCF Growth3 Y	7.82%
FCF Growth5 Y	16.21%
OCF Growth	-14.31%
OCF Growth Q	56.72%
OCF Growth10 Y	3.71%
OCF Growth3 Y	4.51%
OCF Growth5 Y	9.85%
Revenue Growth	2.89x
Revenue Growth Q	4.88x
Revenue Growth3 Y	4.36x
Revenue Growth5 Y	9.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.54
Assets	EUR 111.6B
Cash	EUR 4.9B
Current Assets	EUR 29.7B
Current Liabilities	EUR 22.8B
Debt	EUR 42.6B
Debt EBITDA	EUR 1.64
Debt Equity	EUR 1.07
Debt FCF	EUR 3.48
Equity	EUR 39.8B
Interest Coverage	16.11
Liabilities	EUR 71.8B
Long Term Assets	EUR 81.9B
Long Term Liabilities	EUR 48.9B
Net Cash	EUR -37.7B
Net Cash By Market Cap	EUR -16.11
Net Debt EBITDA	EUR 1.47
Net Debt Equity	EUR 0.95
Net Debt FCF	EUR 3.08
Tangible Book Value	EUR -1.3B
Tangible Book Value Per Share	EUR -0.51
WACC	4.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.3
Inventory Turnover	2.42
Net Working Capital	EUR 4.2B
Quick ratio	0.7
Working Capital	EUR 7B
Working Capital Turnover	EUR 6.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.79%
Dividend Growth	-2.44%
Dividend Growth Years	0%
Dividend per share	EUR 2.86
Dividend Years	10
Dividend Yield	3%
Ex Div Date	2026-03-16
Last Dividend	EUR 0.74
Payout Frequency	Quarterly
Payout Ratio	92.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	40.54%
200-day SMA	85.72
3Y total return	-1.94%
50-day SMA	100.2
50-day SMA vs 200-day SMA	50over200
5Y total return	73.3%
All Time High	124.6
All Time High Change	-23.48%
All Time High Date	2024-06-26
All Time Low	43.36
All Time Low Change	119.88%
All Time Low Date	2018-04-04
ATR	1.98
Beta	0.2
Ch YTD	5.35
High	95.61
High52	105.6
High52 Date	2026-03-30
High52ch	-9.77%
Low	95.19
Low52	66.1
Low52 Date	2025-05-15
Low52ch	44.15%
Ma50ch	-4.86%
Price vs 200-day SMA	11.22%
RSI	41.63
RSI Monthly	53.68
RSI Weekly	53.78
Sharpe ratio	1.11x
Sortino ratio	2.03
Total Return	4.79%
Tr YTD	6.14
Tr1m	-5.98%
Tr1w	-1.76%
Tr3m	-7.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 21.3B
Operating Income Growth	0.5
Operating Income Growth Q	1.06
Operating Income Growth3 Y	7.38
Operating Income Growth5 Y	17.25
Operating margin	37.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,465,769,316%
Net Borrowing	11,700,179,676
Shares Insiders	0.05%
Shares Institutions	80%
Shares Qo Q	-0.64%
Shares Yo Y	-1.79%
Short Ratio	2.79

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 11.5B
Average Volume	289.05x
Bv Per Share	16.11
CAPEX	EUR -3.3B
Ch1m	-5.98
Ch1w	-1.76
Ch1y	35.62
Ch3m	-7.79
Ch3y	-10.56
Ch5y	48.07
Ch6m	27.8
Change	0.57%
Change From Open	-0.35
Close	94.74
Days Gap	0.92
Depreciation Amortization	4,226,242,608
Earnings Date	2026-04-30
EBIT	EUR 21.3B
EBITDA	EUR 25.6B
EPS	EUR 3.1
F Score	4
FCF	EUR 12.2B
FCF EV Yield	4.52x
Financing CF	738,939,600
Fiscal Year End	December
Founded	1,891
Goodwill	18,299,867,922
Graham Number	33.9762
Graham Upside	-64.34
Income Tax	EUR 2.3B
Investing CF	-19,483,027,200
Is Primary Listing	0
Last Earnings Date	2026-02-03
Last Report Date	2026-03-31
Lynch Fair Value	EUR 15.8
Lynch Upside	-83.42
Ma150	90.76
Ma150ch	5.05%
Ma20	97.46
Ma20ch	-2.18%
Net CF	-2,891,578,200
Open	95.61
P FCF Ratio	19.09
P OCF Ratio	15.06
Payment Date	2026-04-07
Position In Range	21.43
Ppne	21,566,217,546
Price Date	2026-05-08
Price EBITDA	EUR 9.13
Relative Volume	1.92x
Revenue	57,040,586,400x
SBC By Revenue	1.23x
Share Based Comp	702,513,000
Tax By Revenue	4.1x
Tax Rate	23.17%
Tr6m	29.88%
Z Score	3.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

VIE/MRK dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.0%

$2.86 annual per share

Payout ratio

+92.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.1%

0 consecutive years of growth

Total shareholder yield

+4.8%

Next ex-dividend date: 2026-03-16

Performance

VIE/MRK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VIE/MRK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VIE/MRK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.6

Neutral momentum band

Price vs 200-day MA

+11.2%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

1.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VIE/MRK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current vie/MRK stock rating?

vie/MRK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full vie/MRK analysis?

The full report lives at /stocks/vie/MRK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for vie/MRK?

The latest report frames vie/MRK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the vie/MRK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.